It is supplied strictly for laboratory and scientific research purposes only
Eli Lilly needs to finish Phase 3 trials (mid-2026), submit a New Drug Application (late 2026), and wait for the FDA to review it (6 to 10 months)
The glucagon receptor activation is entirely new to your body, and the triple receptor profile creates a different physiological response than single or dual agonists
Practical tips for abdominal injection of retatrutide: Pinch a fold of skin between your thumb and forefinger, pulling the tissue away from the abdominal wall Insert the needle at a 45 to 90 degree angle depending on the amount of subcutaneous fat (more fat = steeper angle is fine) Inject slowly over 5 to 10 seconds Hold the needle in place for 5 seconds after injection before withdrawing Do not massage the area after injection, this can alter absorption rate Rotate at least 1.5 inches from the previous injection site The anterior thigh: the reliable alternative The front of the thigh provides an excellent alternative injection site, particularly for people who find abdominal injections uncomfortable or who need to rotate away from the abdomen to allow tissue recovery
Digestive tolerance, medication history, hydration, nutrition, and risk factors need review
In the OASIS 4 trial, participants taking oral semaglutide alongside lifestyle support achieved an average weight loss of almost 17% of their body weight over 64 weeks